Aernoud Fiolet

213 The efficacy and safety of low-dose colchicine in patients with coronary disease REFERENCES 1. Nidorf Stefan M, Fiolet Aernoud TL, Mosterd Arend, Eikelboom John W, Schut Astrid, Opstal Tjerk SJ, The Salem HK, Xu Xiao-Fang, Ireland Mark A, Lenderink Timo, Latchem Donald, Hoogslag Pieter, Jerzewski Anastazia, Nierop Peter, Whelan Alan, Hendriks Randall, Swart Henk, Schaap Jeroen, Kuijper Aaf FM, Hessen MaartenWJ van, Saklani Pradyot, Tan Isabel, Thompson Angus G, Morton Allison, Judkins Chris, Bax Willem A, Dirksen Maurits, Alings Marco MW, Hankey Graeme J, Budgeon Charley A, Tijssen Jan GP, Cornel Jan H, Thompson Peter L. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med 2020;383:1838–1847. 2. Tong David C, Quinn Stephen, Nasis Arthur, Hiew Chin, Roberts-Thomson Philip, Adams Heath, Sriamareswaran Rumes, Htun Nay M, Wilson William, Stub Dion, Gaal William van, Howes Laurie, Collins Nicholas, Yong Andy S, Bhindi Ravinay, Whitbourn Robert, Lee Astin, Hengel Chris, Asrress Kaleab, Freeman Melanie, Amerena John, Wilson Andrew, Layland Jamie, C. Tong David, Stephen Quinn, Arthur Nasis, Chin Hiew, Philip Roberts-Thomson, Heath Adams, Rumes Sriamareswaran, M. Htun Nay, William Wilson, Dion Stub, William van Gaal, Laurie Howes, Nicholas Collins, S. Yong Andy, Ravinay Bhindi, Robert Whitbourn, Astin Lee, Chris Hengel, Kaleab Asrress, Melanie Freeman, John Amerena, Andrew Wilson, Jamie Layland. Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial. Circulation ; 2020;142:1890–1900. 3. Tardif Jean-Claude Claude, Kouz Simon, Waters David D, Bertrand Olivier F, Diaz Rafael, Maggioni Aldo P, Pinto Fausto J, Ibrahim Reda, Gamra Habib, Kiwan Ghassan S, Berry Colin, López-Sendón José, Ostadal Petr, Koenig Wolfgang, Angoulvant Denis, Grégoire Jean C, Lavoie Marc André, Dubé Marie Pierre, Rhainds David, Provencher Mylène, Blondeau Lucie, Orfanos Andreas, L’Allier Philippe L, Guertin Marie Claude, Roubille François. Efficacy and Safety of Low- Dose Colchicine after Myocardial Infarction. N Engl J Med ; 2019;381:2497–2505. 4. Nidorf StefanM, EikelboomJohnW, Budgeon CharleyA, Thompson Peter L. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol ; 2013; 61 :404–410. 5. Tardif Jean-Claude, L’Allier Philippe L, Guertin Marie-Claude. Low-Dose Colchicine after Myocardial Infarction. Reply. N Engl J Med ; 2020;382:1668. 6. Samuel Michelle, Tardif Jean-Claude, Khairy Paul, Roubille François, Waters David D, Grégoire Jean C, Pinto Fausto J, Maggioni Aldo P, Diaz Rafael, Berry Colin, Koenig Wolfgang, Ostadal Petr, Lopez-Sendon Jose, Gamra Habib, Kiwan Ghassan S, Dubé Marie-Pierre, Provencher Mylène, Orfanos Andreas, Blondeau Lucie, Kouz Simon, L’Allier Philippe L, Ibrahim Reda, Bouabdallaoui Nadia, Mitchell Dominic, Guertin Marie-Claude, Lelorier Jacques. Cost-Effectiveness of Low- Dose Colchicine after Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Hear J - Qual Care Clin Outcomes ; 2020; 7. Deftereos Spyridon, Giannopoulos Georgios, Raisakis Konstantinos, Kossyvakis Charalambos, Kaoukis Andreas, Panagopoulou Vasiliki, Driva Metaxia, Hahalis George, Pyrgakis Vlasios, Alexopoulos Dimitrios. Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients. J Am Coll Cardiol ; 2013;61:1679–1685.